4 Item 1A. Risk Factors 26 Item 1B. Unresolved Staff Comments 75 Item 1C. Cybersecurity 75 Item 2. Properties 76 Item 3. Legal Proceedings 76 Item 4. Mine Safety Disclosures 76 PART II 77 Item 5. Market for Registrant's Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities 77 Item 6. [Reserved] 77 Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 78 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 90 I...
Q2 FY2026 — expected 2026-09-07
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-25 | 2025-12-31 | 0001193125-26-122778 | EDGAR | 101K words |
| 2025-03-31 | 2024-12-31 | 0000950170-25-047208 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001193125-25-269689 | EDGAR | 68K words |
| 2025-08-12 | 2025-06-30 | 0000950170-25-107306 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0000950170-25-071375 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-25 | 0001193125-26-122774 | EDGAR | 3K words |
| 2026-02-04 | 0001193125-26-037747 | EDGAR | — |
| 2025-11-06 | 0001193125-25-269624 | EDGAR | — |
| 2025-10-06 | 0001193125-25-230926 | EDGAR | — |
| 2025-09-11 | 0001193125-25-200760 | EDGAR | — |
| 2025-09-02 | 0001193125-25-193353 | EDGAR | — |
| 2025-08-12 | 0000950170-25-107299 | EDGAR | — |
| 2025-05-14 | 0000950170-25-071357 | EDGAR | — |
| 2025-03-31 | 0000950170-25-047207 | EDGAR | — |
18 total filings indexed. 4 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001842295 |
| Ticker | MAZE |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.mazetx.com |
| Listed | 2025-01-31 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report